Save Product
Product Details
Synonym
TNFSF13B, BAFF, BLYS, CD257, DTL, TALL1, THANK, TNFSF20, ZTNF4, TALL-1
Source
Biotinylated Human BAFF Protein, Avitag,Fc Tag (BAF-H82F3) is expressed from human 293 cells (HEK293). It contains AA Ala 134 - Leu 285 (Accession # AAH20674.1).
Predicted N-terminus: Gly
Request for sequenceMolecular Characterization
Other Tags and Version Biotin & Other Labeled Version
This protein carries an Avi tag (Avitag™) at the N-terminus, followed by a human IgG1 Fc tag.
The protein has a calculated MW of 44.9 kDa. The protein migrates as 50-55 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Labeling
Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.
Protein Ratio
Passed as determined by the HABA assay / binding ELISA.
Purity
>95% as determined by SDS-PAGE.
Formulation
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Customers Also Viewed
Performance Data
SDS-PAGE
Biotinylated Human BAFF Protein, Avitag,Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).
SEC-MALS
The purity of Biotinylated Human BAFF Protein, Avitag,Fc Tag (Cat. No. BAF-H82F3) is more than 85% and the molecular weight of this protein is around 280-320 kDa verified by SEC-MALS.
Report
Bioactivity-ELISA
Immobilized Human BCMA, Fc Tag (Cat. No. BC7-H5254) at 5 μg/mL (100 μL/well) can bind Biotinylated Human BAFF Protein, Avitag,Fc Tag (Cat. No. BAF-H82F3) with a linear range of 1.95-15.6 ng/mL (QC tested).
Protocol
Immobilized Human TACI Protein, Fc Tag at 2 μg/mL (100 μL/well) can bind Biotinylated Human BAFF Protein, Avitag,Fc Tag (Cat. No. BAF-H82F3) with a linear range of 0.2-6 ng/mL (Routinely tested).
Protocol
Serial dilutions of Anti-BAFFR Antibody, Human IgG1 were added into Human BAFFR Protein, Llama IgG2b Fc Tag (Cat. No. BAR-H5258): Biotinylated Human BAFF Protein, Avitag,Fc Tag (Cat. No. BAF-H82F3) binding reactions. The half maximal inhibitory concentration (IC50) is 0.8129 μg/mL (Routinely tested).
Protocol
Serial dilutions of Anti-BAFFR Antibody, Human IgG1 were added into Human BAFFR, Fc Tag: Biotinylated Human BAFF Protein, Avitag,Fc Tag (Cat. No. BAF-H82F3) binding reactions. The half maximal inhibitory concentration (IC50) is 0.4692 μg/mL (Routinely tested).
Protocol
Bioactivity-SPR
Immobilized Biotinylated Human BAFF Protein, Avitag,Fc Tag (Cat. No. BAF-H82F3) on SA Chip can bind Human TACI Protein, Fc Tag with an affinity constant of 0.988 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
Protocol
Immobilized Biotinylated Human BAFF Protein, Avitag,Fc Tag (Cat. No. BAF-H82F3) on SA Chip can bind Human BAFFR, Fc Tag with an affinity constant of 26.7 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
Protocol
Bioactivity-BLI
Loaded Biotinylated Human BAFF Protein, Avitag,Fc Tag (Cat. No. BAF-H82F3) on SA Biosensor, can bind Human BCMA, His Tag (Cat. No. BCA-H522y) with an affinity constant of 1 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Protocol
Customer Reviews Writing Reviews
Background
Recent Advances
Drug Development Progress- English Name：
B-cell-activating factor/B lymphocyte stimulator
- Category：
- Approved Drugs：
2 Details
- Drugs in Clinical Trials：
8 Details
- Highest Development Stage：
Approved
Contact Us
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
Drug Candidate Licensing
